IN2014DN00185A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN00185A IN2014DN00185A IN185DEN2014A IN2014DN00185A IN 2014DN00185 A IN2014DN00185 A IN 2014DN00185A IN 185DEN2014 A IN185DEN2014 A IN 185DEN2014A IN 2014DN00185 A IN2014DN00185 A IN 2014DN00185A
- Authority
- IN
- India
- Prior art keywords
- formula
- alzheimer
- salt
- compound represented
- diagnostic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011140069 | 2011-06-24 | ||
| PCT/JP2012/063726 WO2012176587A1 (ja) | 2011-06-24 | 2012-05-29 | 新規アミロイド親和性化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN00185A true IN2014DN00185A (pt) | 2015-07-10 |
Family
ID=47422429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN185DEN2014 IN2014DN00185A (pt) | 2011-06-24 | 2012-05-29 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9211350B2 (pt) |
| EP (1) | EP2725027B1 (pt) |
| JP (1) | JP5167436B2 (pt) |
| KR (1) | KR101854228B1 (pt) |
| CN (1) | CN103596950B (pt) |
| AU (1) | AU2012274639B2 (pt) |
| CA (1) | CA2839199C (pt) |
| ES (1) | ES2619830T3 (pt) |
| IN (1) | IN2014DN00185A (pt) |
| TW (1) | TWI554511B (pt) |
| WO (1) | WO2012176587A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6754353B2 (ja) * | 2014-08-29 | 2020-09-09 | シーエイチディーアイ ファウンデーション，インコーポレーテッド | ハンチントンタンパク質のイメージング用プローブ |
| EP3684781A4 (en) * | 2017-09-19 | 2022-06-29 | The Governors of the University of Alberta | Bioreductively-activated compounds, their prodrugs, radiopharmaceuticals, the compositions, and their applications in multimodal theranostic management of hypoxia diseases including cancer |
| JP6831802B2 (ja) * | 2018-01-12 | 2021-02-17 | 上海富吉医療器械有限公司Ｓｈａｎｇｈａｉ Ｃｈａｒｔｗｅｌｌ Ｍｅｄｉｃａｌ Ｉｎｓｔｒｕｍｅｎｔ Ｃｏ．， Ｌｔｄ． | 放射性核種標識化合物及びこれを含有するイメージング剤 |
| JPWO2022244680A1 (pt) * | 2021-05-18 | 2022-11-24 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2340394A1 (en) | 1998-08-20 | 2000-03-02 | Jorge R. Barrio | Methods for labeling .beta.-amyloid plaques and neurofibrillary tangles |
| JP5022554B2 (ja) | 2000-08-24 | 2012-09-12 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | アルツハイマー病の生前診断ならびにアミロイド沈着物のインビボ画像化および予防に用いるためのチオフラビン誘導体 |
| TWI245764B (en) | 2001-04-23 | 2005-12-21 | Hank F Kung | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| DK1432453T3 (da) | 2001-08-27 | 2013-11-18 | Univ Pennsylvania | Stilbenderivater og anvendelse heraf til binding og billeddannelse af amyloid-plaques |
| WO2007033080A2 (en) * | 2005-09-12 | 2007-03-22 | Emory University | Alzheimer's disease imaging agents |
| EP1956013B1 (en) | 2005-11-30 | 2016-04-13 | Fujifilm RI Pharma Co., Ltd. | Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| TW200808795A (en) | 2006-05-19 | 2008-02-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity for amyloid |
| WO2007148755A1 (ja) * | 2006-06-21 | 2007-12-27 | Nihon Medi-Physics Co., Ltd. | 新規アミロイド親和性化合物 |
| US8207189B2 (en) | 2006-11-30 | 2012-06-26 | Nihon Medi-Physics Co., Ltd. | Compound having affinity for amyloid |
| KR20090101469A (ko) | 2007-01-22 | 2009-09-28 | 아스트라제네카 아베 | 신규 헤테로아릴 치환된 이미다조〔１，２ａ〕피리딘 유도체 |
| CA2703649A1 (en) | 2007-10-24 | 2009-04-30 | Shigeyuki Tanifuji | Novel compound having affinity for amyloid |
| AU2008314871A1 (en) | 2007-10-26 | 2009-04-30 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
| US20100249419A1 (en) | 2007-10-30 | 2010-09-30 | Nihon Medi-Physics Co., Ltd. | Utilization of novel compounds with amyloid affinity and method of producing the same |
| CN101918039B (zh) | 2007-10-30 | 2012-01-04 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物的应用及制备方法 |
| US20100267952A1 (en) | 2007-10-30 | 2010-10-21 | Nihon Medi-Physics Co., Ltd. | Use of novel compound having affinity for amyloid, and process for production of the same |
| US20110076230A1 (en) * | 2008-05-30 | 2011-03-31 | Barrow James C | Novel Substituted Indoles |
| EP2218464A1 (en) * | 2009-02-11 | 2010-08-18 | Technische Universität München | Compounds for non-invasive measurement of aggregates of amyloid peptides |
| JPWO2010128595A1 (ja) | 2009-05-07 | 2012-11-01 | 富士フイルムＲｉファーマ株式会社 | 放射性ヨウ素標識イミダゾピリジン誘導体の製造法 |
| WO2011045415A2 (en) | 2009-10-15 | 2011-04-21 | Guerbet | New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| CN103534253B (zh) * | 2011-05-20 | 2016-02-24 | 日本医事物理股份有限公司 | 对淀粉状蛋白具有亲和性的化合物 |
-
2012
- 2012-05-29 KR KR1020137032274A patent/KR101854228B1/ko active IP Right Grant
- 2012-05-29 EP EP12802179.7A patent/EP2725027B1/en active Active
- 2012-05-29 AU AU2012274639A patent/AU2012274639B2/en not_active Ceased
- 2012-05-29 IN IN185DEN2014 patent/IN2014DN00185A/en unknown
- 2012-05-29 ES ES12802179.7T patent/ES2619830T3/es active Active
- 2012-05-29 WO PCT/JP2012/063726 patent/WO2012176587A1/ja active Application Filing
- 2012-05-29 CN CN201280027545.0A patent/CN103596950B/zh active Active
- 2012-05-29 CA CA2839199A patent/CA2839199C/en not_active Expired - Fee Related
- 2012-05-29 JP JP2012540219A patent/JP5167436B2/ja active Active
- 2012-05-29 US US14/128,903 patent/US9211350B2/en active Active
- 2012-05-31 TW TW101119585A patent/TWI554511B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN103596950B (zh) | 2017-12-19 |
| CN103596950A (zh) | 2014-02-19 |
| TW201300388A (zh) | 2013-01-01 |
| TWI554511B (zh) | 2016-10-21 |
| JPWO2012176587A1 (ja) | 2015-02-23 |
| AU2012274639B2 (en) | 2016-08-11 |
| CA2839199C (en) | 2018-11-06 |
| JP5167436B2 (ja) | 2013-03-21 |
| EP2725027A4 (en) | 2015-02-25 |
| ES2619830T3 (es) | 2017-06-27 |
| CA2839199A1 (en) | 2012-12-27 |
| EP2725027B1 (en) | 2017-03-01 |
| KR101854228B1 (ko) | 2018-05-03 |
| US20140121377A1 (en) | 2014-05-01 |
| EP2725027A1 (en) | 2014-04-30 |
| KR20140040735A (ko) | 2014-04-03 |
| US9211350B2 (en) | 2015-12-15 |
| AU2012274639A1 (en) | 2014-02-06 |
| WO2012176587A1 (ja) | 2012-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015012006A (es) | Inhibidores de bromodominio tetraciclicos. | |
| PH12015502502A1 (en) | Heteroaromatic compounds and their use as dopamine d1 ligands | |
| WO2014152389A8 (en) | Imaging agent for detection of diseased cells | |
| PH12015501993A1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| MX2014012695A (es) | Derivados de isoindolona. | |
| MX2020003112A (es) | Composiciones de biguanida y metodos para tratar trastornos metabolicos. | |
| MX2016006336A (es) | Compuestos pirazolopirimidina. | |
| TN2012000369A1 (en) | 5-alkynyl-pyrimidines | |
| MX2014002014A (es) | Formulaciones, uso de las mismas como o para producir detergentes para lavado de vajillas y produccion de las mismas. | |
| MX2013011589A (es) | Metodos y composiciones para tratar enfermedad de parkinson. | |
| MX2016007128A (es) | Compuestos del receptor 6 de quimiocina (ccr6). | |
| MX2016007440A (es) | Inhibidores del bromodominio. | |
| WO2013040227A3 (en) | Therapeutic compounds | |
| MX2017003470A (es) | Inhibidores macrociclicos de cinasa lrrk2. | |
| IN2014DN00185A (pt) | ||
| WO2013155528A3 (en) | Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels | |
| PH12015500012B1 (en) | Benzodioxole derivative and preparation method and use thereof | |
| PH12015501146A1 (en) | Hydantoin derivative | |
| IN2015DN00209A (pt) | ||
| IN2014DN09826A (pt) | ||
| PH12015501056A1 (en) | 2-pyridone compound | |
| MX358494B (es) | Derivado de acido pirrolidin-3-ilacetico. | |
| WO2013111013A3 (en) | Methods for treating alzheimer's disease by administering certain synthetic compounds | |
| EA201690908A1 (ru) | Пиразолопиримидиновые соединения | |
| IN2012DN06600A (pt) |